Clinical Trial

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

Recruiting
View on ClinicalTrials.gov →
Summary
This study is to evaluate the effectiveness of nsPFA in treating papillary thyroid microcarcinoma. T
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-03
Trial Details
NCT Number NCT07218315
Lead Sponsor M.D. Anderson Cancer Center
Conditions Thyroid Carcinoma
Enrollment 15 participants
Start Date 2026-02-11
Primary Completion 2029-01-31 (estimated)
Study Completion 2031-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-30